Injectable-Heavy Care Generates Real Regulated Waste
Ophthalmology runs a heavier waste profile than most eye care. Intravitreal anti-VEGF injections, cataract and other surgical procedures, and in-office anesthetics produce a steady flow of contaminated sharps, expired injectable drugs, and procedure biohazard well beyond what an optometry office generates. A high-volume retina practice giving injections all day, combined with a surgical schedule, means multiple regulated streams moving at once. Improper handling risks needlestick exposure for staff and citations for your practice, and because these streams differ by rule and by risk, each needs its own compliant route rather than one generic waste bin. The practice that treats injection sharps, surgical sharps, expired drugs, and biohazard as one undifferentiated pile is the practice most likely to end up with the wrong item in the wrong container.
The Frameworks Covering Each Stream
Injection and surgical sharps and blood-contaminated biohazard fall under OSHA's Bloodborne Pathogens Standard, 29 CFR 1910.1030, which requires FDA-cleared puncture-resistant containers, an exposure control plan, and annual training. Expired anti-VEGF and other injectables are managed as pharmaceutical waste, destroyed with documentation rather than drain-disposed; any drug meeting EPA hazardous-waste criteria is handled under RCRA, 40 CFR. Shipping regulated medical waste for destruction is governed by DOT's rules and the UN3291 packaging standard. If your practice uses sedation, expired or wasted controlled sedatives fall under DEA 21 CFR 1317, requiring non-retrievable destruction and a Form 41 for surrendered stock. Several frameworks converge in one procedure suite, which is why segregation at the point of use, not sorting after the fact, is what keeps an ophthalmology practice compliant.
Intravitreal and Surgical Sharps
Sharps in ophthalmology come from two distinct sources: intravitreal injection needles used in high-frequency anti-VEGF care, and surgical blades, needles, syringes, and cannulas from procedures. Both go into FDA-cleared, puncture-resistant containers kept upright, closable, and out of reach, and both containers should be swapped at the fill line rather than topped off. The injection side is what surprises practices on volume, because a retina clinic can generate injection sharps continuously through a clinic day, while the surgical side generates sharper, more varied items in shorter bursts. Bloody gauze belongs in biohazard, not sharps, and expired drugs belong in the pharmaceutical stream. Sizing container service to both your injection cadence and your procedure schedule keeps either source from overwhelming a container mid-session, which is when overreach exposures occur.
Expired Anti-VEGF and Injectable Drugs
Expired anti-VEGF agents, topical and injectable anesthetics, and other expired non-controlled ophthalmic medications are pharmaceutical waste. They must be destroyed with documentation, never drained or thrown in the trash, and they should be kept out of the sharps and biohazard containers. Before anything routes to the pharmaceutical kit, segregate two categories that travel their own path: any RCRA-hazardous drug, handled under EPA 40 CFR, and any controlled sedative, routed to DEA non-retrievable destruction. Everything non-controlled and non-hazardous then consolidates into the pharmaceutical stream. The discipline is doing the sort when the vial is pulled, because a high-cost injectable that has expired is easy to set down in whatever container is closest, and once it is commingled with sharps or biohazard the documentation trail for that drug is broken.